Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Anna‐Leena Sirén(University of Würzburg), Pietro Ghezzi(Brighton and Sussex Medical School), Annalisa Capobianco(Vita-Salute San Raffaele University), Michael Brines(Northwell Health), Christoph G. Goemans(Mario Negri Institute for Pharmacological Research), Maddalena Fratelli(Mario Negri Institute for Pharmacological Research), Piotr Lewczuk(Universitätsklinikum Erlangen), Hannelore Ehrenreich(Max Planck Institute of Experimental Medicine), Tiziana Mennini(Mario Negri Institute for Pharmacological Research), Claudio Pasquali(Mario Negri Institute for Pharmacological Research), Sonja Keenan(Mario Negri Institute for Pharmacological Research), Simona Casagrande(Mario Negri Institute for Pharmacological Research), Rolf Heumann(Mario Negri Institute for Pharmacological Research), Christoph H. Gleiter(University of Tübingen), Anthony Cerami(Araim Pharmaceuticals (United States))
Cited by 1,026
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Clinical Relevance of Biomarkers of Oxidative Stress
|Antioxidants and Redox Signaling|2015|906
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
|Proceedings of the National Academy of Sciences|2004|654